Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed. This indicates a minor platform update with no changes to study page content or visible functionality.
    Difference
    0.0%
    Check dated 2026-03-11T17:04:50.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A minor site update adds Revision: v3.4.2 and removes the previous maintenance notice (Revision: v3.4.1) related to government funding.
    Difference
    0.3%
    Check dated 2026-02-11T04:55:23.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding notice and site status message are now displayed, and the revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:36:54.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated wording for No FEAR Act data, capitalization of QC criteria labels, and revision notes (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:08:54.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3. No substantive changes to the study content (e.g., eligibility criteria, outcomes, or interventions) are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:48:44.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page’s Locations section was updated with additions and removals of study sites across multiple states and countries (e.g., CA, CT, FL, KY, NY, NC, OH, TN, UT, WA, and European locations).
    Difference
    1%
    Check dated 2025-12-23T10:13:44.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.